Myocarditis reported after BNT162b2 vaccination in Israel
Patients view perinatal depression screenings as ineffective, study finds
13 October 2021WHO unveils new pandemic pathogen sleuth squad
13 October 2021Myocarditis reported after BNT162b2 vaccination in Israel
(HealthDay)—The incidence of myocarditis is low but increased among individuals aged 16 years and older who have received the Pfizer-BioNTech BNT162b2 mRNA vaccine, with the highest incidence among young men, according to two studies published online Oct. 6 in the New England Journal of Medicine.
